As of 30 Sep 2025, 42 institutional investors reported holding $299,324,000 in principal (par value) of HAEMONETICS CORP MASS - NOTE 3/0.
| Period | Principal | Value | Change | Price (% of par) (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | $830,000 | $819,608 | +$15,783 | 98.58% | 2 |
| 2025 Q3 | $299,324,000 | $293,438,296 | +$142,109 | 97.77% | 42 |
| 2025 Q2 | $297,562,000 | $287,850,876 | +$2,025,248 | 96.5% | 43 |
| 2025 Q1 | $295,109,639 | $282,286,333 | +$2,783,564 | 95.44% | 44 |
| 2024 Q4 | $292,307,277 | $275,910,996 | -$9,149,307 | 94.13% | 45 |
| 2024 Q3 | $303,732,277 | $281,293,777 | -$18,502,268 | 92.5% | 51 |
| 2024 Q2 | $324,676,273 | $293,289,879 | -$199,609,133 | 90.15% | 47 |
| 2024 Q1 | $538,925,331 | $504,149,482 | -$13,351,655,804 | 91.96% | 49 |
| 2023 Q4 | $495,645,344 | $449,607,635 | +$10,255,347 | 89.05% | 47 |
| 2023 Q3 | $471,885,170 | $441,057,607 | +$4,504,193 | 86.83% | 51 |
| 2023 Q2 | $467,571,318 | $429,340,834 | +$8,940,273 | 85.44% | 51 |
| 2023 Q1 | $468,939,829 | $414,748,638 | -$7,586,940,375 | 85.06% | 47 |
| 2022 Q4 | $438,119,918 | $371,006,023 | -$4,862,769 | 83.13% | 49 |
| 2022 Q3 | $442,070,040 | $346,025,777 | -$924,569 | 79.99% | 49 |
| 2022 Q2 | $446,406,179 | $346,025,363 | -$7,021,150,598 | 78.75% | 43 |
| 2022 Q1 | $438,704,655 | $324,149,991 | +$324,143,704 | 84.15% | 34 |